Portland

News

London-headquartered communications consultancy Portland has welcomed back former health minister James O’Shaughnessy to the fold.

News

Immunovant shares were sliding today after it reported that FcRn blocker batoclimab failed a pair of phase 3 trials in thyroid eye disease.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.